NEWS & MEDIA
Spain - December 14, 2016
Recently StemTek was selected by the European Commission Horizon 2020 SME Instrument for being one of the top innovative SMEs in its sector. Significantly, Horizon 2020 is the biggest EU Research and Innovation program ever with nearly €80 billion of funding. By winning Phase I, StemTek will receive €50.000 in funding and is eligible to participate in Phase II for up to €2.5 million in funding and mentorship. With this funding our goal is to expand and ramp up scalable producti...
www.genengnews.com - December 09, 2016
Cell2Sphere is a 3D cell culture kit created specifically for use in cancer stem-cell research, pharmaceutical drug development, and personalized medicine. Cell2Sphere frozen spheroid tissue culture samples increase the shelf life of today’s 3D cultures, enhancing the biological relevance of preclinical in vitro 3D culture efficacy assays. See the Source and the full article here.
www.elmundo.es - December 05, 2016
The spanish start up StemTek Therapeutics has launched a unique ready-to-use kit that democratizes the use of cancer stem cell enriched 3D cell cultures providing a convenient and biologically relevant system for drug discovery. See the Source and the full article here.
- November 17, 2016
In this radio broadcast Elixabete Legarda interviews Angel Garcia. They talk about the beginnins, goals and future of Stemtek Therapeutics.
Bilbao, Spain & Cologne, Germany - November 07, 2016
A geometric evolution of cell based assay development for drug discovery. StemTek Therapeutics, a leading Spanish biotech start up, today announced the availability of Cell2Sphere, an innovative 3D cell culture kit created specifically for use in cancer stem cell research, pharmaceutical drug development and personalized medicine. Cell2Sphere frozen spheroid tissue culture samples increase the shelf life of today’s 3D cultures, enhancing the biological relevance of pre-clinical in vi...